Medical and Pharmaceutical Journal

Iraqi Medical Research Center

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Medical and Pharmaceutical Journal is an open-access journal published by Iraqi Medical Research Center in Iraq, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Iraqi Medical Research Center
ISSN
2957-6067
Country
Iraq
Languages
english
Access
Open access
Articles in DOAJ
6
Declared review time
8 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2026-01-16
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2025
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

6

Most recent article

8 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

85

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

10

i10-index

11

From OpenAlex open data (CC0).

Editorial & policy10
Added to DOAJ
2026-01-16
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
PKP PN
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
50%
Enrolled in Crossref Similarity Check
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • COVID-19 Clinical Research Studies
  • Liver Disease and Transplantation
  • Pharmacological Receptor Mechanisms and Effects
  • Diverse Scientific Research Studies
  • Antibiotic Use and Resistance
  • Pharmaceutical Practices and Patient Outcomes
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
Show all subjects (50)
  • Liver Disease Diagnosis and Treatment
  • Pharmaceutical Practices and Patient Outcomes
  • Drug-Induced Hepatotoxicity and Protection
  • Ethnobotanical and Medicinal Plants Studies
  • Pharmacological Effects of Natural Compounds
  • Drug-Induced Hepatotoxicity and Protection
  • Antibiotic Use and Resistance
  • Skin Protection and Aging
  • Pharmaceutical studies and practices
  • Pharmaceutical Quality and Counterfeiting
  • Regulation of Appetite and Obesity
  • Pharmacological Effects of Natural Compounds
  • Antibiotic Resistance in Bacteria
  • Computational Drug Discovery Methods
  • Parasites and Host Interactions
  • Nanoparticle-Based Drug Delivery
  • Fungal Biology and Applications
  • Skin Protection and Aging
  • Hepatitis B Virus Studies
  • Antimicrobial Resistance in Staphylococcus
  • SARS-CoV-2 and COVID-19 Research
  • Malaria Research and Control
  • Parkinson's Disease Mechanisms and Treatments
  • Food Safety and Hygiene
  • Pharmacogenetics and Drug Metabolism
  • Advanced Drug Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Regulation of Appetite and Obesity
  • Antibiotic Resistance in Bacteria
  • Cancer, Lipids, and Metabolism
  • Metabolism, Diabetes, and Cancer
  • Healthcare Systems and Reforms
  • Climate Change and Health Impacts
  • Parasites and Host Interactions
  • Nanoparticle-Based Drug Delivery
  • Hormonal and reproductive studies
  • COVID-19 Clinical Research Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Malaria Research and Control
  • SARS-CoV-2 and COVID-19 Research
  • Antimicrobial Resistance in Staphylococcus
  • Hepatitis B Virus Studies

Keywords (DOAJ)

  • pharmacology
  • pharmacy
  • pharmacognosy
  • public health
  • pharmaceutic
  • medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: